Summary

Contract Research, synthetic organic chemistry, medicinal chemistry, Anti-viral research, Anti infective research. Corona virus, COVID-19 research, Oncology, Lead Optimization, Organic Chemistry, Parallel synthesis, Building Blocks synthesis, SAR Optimization, Active Pharmaceutical Intermediates, Drug-Protein, Drug Conjugation, Small Molecule, Antibody Drug Conjugates, Pharmaceuticals, peptides, nucleosides, PNA, DNA, RNA.

Description

CreaGen Inc. provides contract research services in organic synthesis, medicinal chemistry, lead optimization, small molecules, chemical library synthesis, conjugation chemistry, and antibody drug conjugation chemistry, analytical and bio-analytical chemistry. We have more than 100 years of combined experience in working with over 48 biotech and pharmaceutical companies and federal institutes. Our 22,000 sq ft facility has a full suite of infrastructure for synthesis, purification and characterization combined with a highly qualified team of chemists putting us in a strong position to deliver unparalleled drug discovery services to biotech, pharmaceutical companies and Federal research laboratories.

Special details

Specialized instruments at CreaGen: 300 MHz Varian multi nuclear NMR; , Waters Micromass Quatro Ultima LCMS (triple-quad MS), Waters Autopurification System with SQ3100 Mass Detector, HP 1200 analytical HPLC; HP-1100 preparative HPLC, Waters chiral SFC and UPLC systems, Sedex 55 ELSD system Teledyne-Isco Combiflash-RF purification system, Waters Alliance HT 2790 Separations Module, Automated parallel synthesis instruments, Parr hydrogenation apparatus; Microwave reactor, Semi-automated parallel synthesizers (TCAMS). Automated liquid handlers and high speed evaporators.

Profile

  • Incorporated in
    Massachusetts
  • Established since
    2003
  • Main/Branch
    Branch

Address